Epocrates Drug Updates — Editor’s Pick
Jan 18, 2012
New Generic Monograph for Cromolyn
The generic formulation of the oral mast cell stabilizer, cromolyn (first-time generic for Gastrocrom), recently became available to treat symptoms of mastocytosis in adult and pediatric patients greater than two years old.
New Generic Monograph for Cromolyn
Recent Updates
- Jan 11, 2012
- New Drug Monograph for Onfi
The FDA recently approved the long-acting benzodiazepine, Onfi (clobazam), for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in adult and pediatric patients greater than two years old. New Drug Monograph for Onfi - Jan 4, 2012
- MedWatch Safety Alert for Multaq
The FDA has completed a safety review for the oral antiarrhythmic, Multaq (dronedarone), concluding that the drug should not be prescribed to patients with permanent atrial fibrillation (AF), due to increased risk of serious cardiovascular events, including death. All non-permanent (paroxysmal or persistent) AF patients receiving Multaq should have electrocardiogram monitoring every 3 months; discontinue Multaq or be cardioverted if found to be in AF; and receive appropriate antithrombotic therapy while taking Multaq. MedWatch Safety Alert for Multaq - Jan 4, 2012
- MedWatch Safety Alert for Infant Acetaminophen Products
The FDA recently communicated a warning for acetaminophen products marketed for infants. A new concentration is available (160 mg/5 mL) which affects the volume of liquid given to an infant. Other infant acetaminophen products are available in 80 mg/0.8 mL and 80 mg/mL concentrations. To avoid confusion and potential dosing errors, instruct caregivers to carefully read and verify the concentration, dosage, and directions for use on the product label and only use the dosing device provided with the product. MedWatch Safety Alert for Infant Acetaminophen Products - Dec 14, 2011
- New Generic Monograph for Caduet
The FDA recently approved the generic formulation for amlodipine/atorvastatin (Caduet) to treat patients who need therapy with both a calcium channel blocker and a statin. New Generic Monograph for Caduet - Dec 7, 2011
- New Generic Monograph for Atorvastatin
The FDA recently approved the generic formulation for atorvastatin (Lipitor) to treat various dyslipidemias in adult and pediatric patients. New Generic Monograph for Atorvastatin - Nov 30, 2011
- Breast Cancer Indication Revoked for Avastin
The FDA recently revoked the approval of Avastin (bevacizumab) for the treatment of breast cancer due to lack of safety and efficacy data for that indication. The drug is still approved for the treatment of metastatic colorectal cancer, progressive glioblastoma multiforme, non-small cell lung cancer, and metastatic renal cell cancer. Breast Cancer Indication Revoked for Avastin
New Drug Monographs
RSS Feed
Top drug searchesThese updates, and hundreds more, are available in all Epocrates mobile and online products. See Products
To update your mobile reference, simply Update (sync). Learn How